Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis

C. L. Haddox, A. A. Mangaonkar, D. Chen, M. Shi, R. He, J. L. Oliveira, M. R. Litzow, A. Al-Kali, W. J. Hogan, M. A. Elliott

Research output: Contribution to journalArticle

11 Scopus citations
Original languageEnglish (US)
Pages (from-to)e607
JournalBlood cancer journal
Volume7
Issue number9
DOIs
StatePublished - Sep 15 2017

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this